Sun, Dian-Min <br/><br/>
MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.  [electronic resource] 

 -  Scientific reports  05 2018 
 - 8007 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-26381-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Adult<br/>Animals<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Case-Control Studies<br/>Cisplatin--therapeutic use<br/>Down-Regulation--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genes, Tumor Suppressor--physiology<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Nude<br/>MicroRNAs--physiology<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Signal Transduction--genetics<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays